ATE251608T1 - Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten - Google Patents
Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthaltenInfo
- Publication number
- ATE251608T1 ATE251608T1 AT96942564T AT96942564T ATE251608T1 AT E251608 T1 ATE251608 T1 AT E251608T1 AT 96942564 T AT96942564 T AT 96942564T AT 96942564 T AT96942564 T AT 96942564T AT E251608 T1 ATE251608 T1 AT E251608T1
- Authority
- AT
- Austria
- Prior art keywords
- represents hydrogen
- compositions containing
- amino
- containing same
- medicinal compositions
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000001257 hydrogen Substances 0.000 abstract 9
- 229910052739 hydrogen Inorganic materials 0.000 abstract 9
- 150000002431 hydrogen Chemical class 0.000 abstract 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- -1 hydroxy, benzyloxy, amino Chemical group 0.000 abstract 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 2
- 239000001301 oxygen Chemical group 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Chemical group 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/10—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP257696 | 1996-01-10 | ||
| PCT/JP1996/003689 WO1997025311A1 (en) | 1996-01-10 | 1996-12-18 | Novel tricyclic compounds and drug compositions containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE251608T1 true ATE251608T1 (de) | 2003-10-15 |
Family
ID=11533209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96942564T ATE251608T1 (de) | 1996-01-10 | 1996-12-18 | Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US6037362A (de) |
| EP (1) | EP0882707B1 (de) |
| JP (1) | JP2000239255A (de) |
| KR (1) | KR100395280B1 (de) |
| CN (2) | CN1083831C (de) |
| AT (1) | ATE251608T1 (de) |
| AU (1) | AU715233B2 (de) |
| CA (1) | CA2242351C (de) |
| DE (1) | DE69630319T2 (de) |
| ES (1) | ES2208772T3 (de) |
| NO (2) | NO312159B1 (de) |
| PT (1) | PT882707E (de) |
| WO (1) | WO1997025311A1 (de) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025355A (en) | 1997-05-19 | 2000-02-15 | Cambridge Neuroscience, Inc. | Pharmaceutically active compounds and methods of use |
| EP0938467B1 (de) * | 1996-11-11 | 2002-06-12 | Sepracor, Inc. | Verfahren zur herstellung von optisch reinen isomeren des formoterols |
| US6040344A (en) * | 1996-11-11 | 2000-03-21 | Sepracor Inc. | Formoterol process |
| US6172099B1 (en) | 1997-07-03 | 2001-01-09 | Asahi Kasei Kogyo Kabushiki Kaisha | Tricyclic compounds having saturated rings and medicinal compositions containing the same |
| EP1070046A1 (de) * | 1998-04-06 | 2001-01-24 | Fujisawa Pharmaceutical Co., Ltd. | Propanolaminderivate |
| US20030073644A1 (en) * | 1998-11-11 | 2003-04-17 | Smithkline Beecham P.L.C. | Combinations comprising a beta-agonist and a further antidiabetic agent |
| CZ20011655A3 (cs) * | 1998-11-11 | 2002-06-12 | Smithkline Beecham Plc | Léčivo pro léčení diabetes mellitus a stavů s ním spojených a farmaceutický prostředek obsahující beta -agonistu a daląí antidiabetické činidlo |
| CA2355079A1 (en) * | 1998-12-15 | 2000-06-22 | Shiro Miyoshi | Novel heterocyclic compounds and drug compositions containing the same |
| TW519537B (en) * | 1999-03-26 | 2003-02-01 | Asahi Chemical Ind | Process for the preparation of tricylic amino-alcohol derivatives |
| WO2000059885A1 (en) * | 1999-04-01 | 2000-10-12 | Asahi Kasei Kabushiki Kaisha | Method for the preparation of tricyclic amino alcohol derivatives through azides |
| CA2377760A1 (en) * | 1999-07-09 | 2001-01-18 | Asahi Kasei Kabushiki Kaisha | Process for the preparation of tricyclic amino alcohol derivatives |
| AU6596800A (en) * | 1999-09-03 | 2001-04-10 | Asahi Kasei Kabushiki Kaisha | Processes for the preparation of tricyclic amino alcohol derivatives |
| US20030220329A1 (en) * | 1999-09-17 | 2003-11-27 | Duke University | Method of improving beta-adrenergic receptor function |
| MXPA02003423A (es) * | 1999-10-04 | 2002-08-20 | Ashai Kasei Kabushiki Kaisha | Metodo para mejorar la solubilidad de los derivados de aminoalcoholes triciclicos. |
| CA2394778A1 (en) * | 1999-12-16 | 2002-06-14 | Shiro Miyoshi | Novel substituted tricyclic compounds |
| US20030018061A1 (en) * | 2000-01-28 | 2003-01-23 | Kohei Ogawa | Novel remedies with the use of beta 3 agonist |
| WO2001083453A1 (en) * | 2000-04-28 | 2001-11-08 | Asahi Kasei Kabushiki Kaisha | Novel substituted tricyclic compounds |
| WO2001083452A1 (en) * | 2000-04-28 | 2001-11-08 | Asahi Kasei Kabushiki Kaisha | Novel tricyclic compounds |
| PT1277736E (pt) * | 2000-04-28 | 2007-10-12 | Asahi Kasei Pharma Corp | Novos compostos bicíclicos |
| GB0010757D0 (en) | 2000-05-05 | 2000-06-28 | Astrazeneca Ab | Chemical compounds |
| WO2002051806A1 (en) * | 2000-12-22 | 2002-07-04 | Astrazeneca Ab | Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| JPWO2002074306A1 (ja) * | 2001-03-19 | 2004-07-08 | 旭化成ファーマ株式会社 | 脂肪肝治療薬 |
| GB0121941D0 (en) * | 2001-09-11 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| KR100816527B1 (ko) * | 2001-09-12 | 2008-04-10 | 한국화학연구원 | 페닐테트라졸 유도체로 치환된 β-아미노알코올 화합물 |
| EP1447400B1 (de) * | 2001-10-25 | 2008-09-17 | Asahi Kasei Pharma Corporation | Bicyclische verbindung |
| AU2003209527A1 (en) | 2002-02-27 | 2003-09-09 | Pfizer Products Inc. | Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol |
| MXPA04008298A (es) | 2002-02-27 | 2004-11-26 | Pfizer Prod Inc | Procesos e intermedios utiles en la preparacion de agonistas de receptor beta-3 adrenergico. |
| US6864268B2 (en) | 2002-02-27 | 2005-03-08 | Pfizer Inc. | β3 adrenergic receptor agonists |
| EP1424079A1 (de) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors |
| MXPA05008587A (es) * | 2003-02-14 | 2005-11-04 | Kissei Pharmaceutical | Derivados de alcohol amino, composiciones farmaceuticas que contienen los mismos, y usos de los mismos. |
| JP4644601B2 (ja) * | 2003-10-24 | 2011-03-02 | キッセイ薬品工業株式会社 | アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途 |
| US8501994B2 (en) | 2007-08-28 | 2013-08-06 | Sunovion Pharmaceuticals Inc. | Acetamide stereoisomer |
| US7718822B2 (en) | 2007-08-28 | 2010-05-18 | Sepracor Inc. | Carbamate Stereoisomer |
| JPWO2010041569A1 (ja) | 2008-10-09 | 2012-03-08 | 旭化成ファーマ株式会社 | インダゾール化合物 |
| EP2351742A4 (de) | 2008-10-09 | 2012-03-28 | Asahi Kasei Pharma Corp | Indazolderivate |
| US20100222404A1 (en) * | 2008-11-04 | 2010-09-02 | Asahi Kasei Pharma Corporation | Indazole derivative dihydrochloride |
| US20120225909A1 (en) * | 2009-09-30 | 2012-09-06 | Asahi Kasei Pharma Corporation | Indazole analog |
| WO2012032546A2 (en) * | 2010-09-08 | 2012-03-15 | Cadila Healthcare Limited | Process for the preparation of salmeterol and its intermediates |
| ES2394349B1 (es) | 2012-08-29 | 2013-11-04 | Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii | Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar |
| WO2014108449A1 (en) | 2013-01-08 | 2014-07-17 | Atrogi Ab | A screening method, a kit, a method of treatment and a compound for use in a method of treatment |
| US10478445B2 (en) | 2013-07-03 | 2019-11-19 | Georgetown University | Boronic acid derivatives of resveratrol for activating deacetylase enzymes |
| US11053255B2 (en) | 2015-06-22 | 2021-07-06 | Georgetown University | Synthesis of mahanine and related compounds |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201903832D0 (en) | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
| GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
| CN115656390B (zh) * | 2022-12-08 | 2023-03-28 | 成都苑东生物制药股份有限公司 | 一种氨酚羟考酮缓释片的含量测定方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL33573A (en) * | 1968-12-30 | 1973-10-25 | Richardson Merrell Inc | Bis-basic ethers and thioethers of fluorenone,fluorenol and fluorene |
| GB1521089A (en) * | 1975-11-12 | 1978-08-09 | Valeas Srl | Aminoethanol derivatives |
| FR2332010A1 (fr) * | 1975-11-18 | 1977-06-17 | Continental Pharma | Amino-alcool heterocyclique, son sel et son procede de preparation |
| DK31578A (da) * | 1977-02-03 | 1978-08-04 | Allen & Hanburys Ltd | Fremgangsmaade til fremstilling af benzenderivater |
| JPS5473751A (en) * | 1977-10-12 | 1979-06-13 | Yamanouchi Pharmaceut Co Ltd | Phenyl ethanolamine derivatives and their preparation |
| CA1147342A (en) * | 1977-10-12 | 1983-05-31 | Kazuo Imai | Process of producing novel phenylethanolamine derivatives |
| JPS5553262A (en) * | 1978-10-17 | 1980-04-18 | Yamanouchi Pharmaceut Co Ltd | Phenylethanolamine derivative |
| DE3061334D1 (en) * | 1979-06-16 | 1983-01-20 | Beecham Group Plc | Ethanamine derivatives, their preparation and use in pharmaceutical compositions |
| JPS5950671B2 (ja) * | 1982-08-26 | 1984-12-10 | 山之内製薬株式会社 | フェニルエタノ−ルアミン誘導体およびその製造法 |
| GB8419797D0 (en) * | 1984-08-03 | 1984-09-05 | Beecham Group Plc | Compounds |
| US5061727A (en) * | 1990-05-04 | 1991-10-29 | American Cyanamid Company | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles |
| US5767133A (en) * | 1993-06-14 | 1998-06-16 | Pfizer Inc. | Secondary amines as antidiabetic and antiobesity agents |
| US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| IL113410A (en) * | 1994-04-26 | 1999-11-30 | Merck & Co Inc | Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them |
| JPH08165276A (ja) * | 1994-12-14 | 1996-06-25 | Dainippon Pharmaceut Co Ltd | ２−アルキルアミノ−１−フェニルエタノール誘導体 |
-
1996
- 1996-12-18 AT AT96942564T patent/ATE251608T1/de not_active IP Right Cessation
- 1996-12-18 ES ES96942564T patent/ES2208772T3/es not_active Expired - Lifetime
- 1996-12-18 AU AU11708/97A patent/AU715233B2/en not_active Ceased
- 1996-12-18 CN CN96180079A patent/CN1083831C/zh not_active Expired - Fee Related
- 1996-12-18 EP EP96942564A patent/EP0882707B1/de not_active Expired - Lifetime
- 1996-12-18 CA CA002242351A patent/CA2242351C/en not_active Expired - Fee Related
- 1996-12-18 PT PT96942564T patent/PT882707E/pt unknown
- 1996-12-18 WO PCT/JP1996/003689 patent/WO1997025311A1/ja not_active Ceased
- 1996-12-18 DE DE69630319T patent/DE69630319T2/de not_active Expired - Lifetime
- 1996-12-18 KR KR10-1998-0705300A patent/KR100395280B1/ko not_active Expired - Fee Related
- 1996-12-18 US US09/101,232 patent/US6037362A/en not_active Expired - Fee Related
-
1998
- 1998-07-10 NO NO19983197A patent/NO312159B1/no not_active IP Right Cessation
-
1999
- 1999-12-28 US US09/472,937 patent/US6187809B1/en not_active Expired - Fee Related
-
2000
- 2000-02-23 JP JP2000045460A patent/JP2000239255A/ja not_active Withdrawn
- 2000-11-02 CN CN00131988A patent/CN1295064A/zh active Pending
- 2000-11-16 US US09/713,202 patent/US6545053B1/en not_active Expired - Fee Related
-
2001
- 2001-06-11 NO NO20012876A patent/NO20012876D0/no not_active Application Discontinuation
-
2002
- 2002-09-30 US US10/259,462 patent/US20030139475A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT882707E (pt) | 2004-02-27 |
| US6037362A (en) | 2000-03-14 |
| EP0882707A1 (de) | 1998-12-09 |
| EP0882707A4 (de) | 2001-04-11 |
| AU715233B2 (en) | 2000-01-20 |
| NO20012876D0 (no) | 2001-06-11 |
| NO20012876L (no) | 1998-09-10 |
| NO983197L (no) | 1998-09-10 |
| EP0882707B1 (de) | 2003-10-08 |
| DE69630319D1 (de) | 2003-11-13 |
| HK1017669A1 (en) | 1999-11-26 |
| CA2242351C (en) | 2003-03-11 |
| KR100395280B1 (ko) | 2004-06-04 |
| AU1170897A (en) | 1997-08-01 |
| CN1209119A (zh) | 1999-02-24 |
| NO312159B1 (no) | 2002-04-02 |
| DE69630319T2 (de) | 2004-07-29 |
| ES2208772T3 (es) | 2004-06-16 |
| CA2242351A1 (en) | 1997-07-17 |
| US20030139475A1 (en) | 2003-07-24 |
| JP2000239255A (ja) | 2000-09-05 |
| US6545053B1 (en) | 2003-04-08 |
| WO1997025311A1 (en) | 1997-07-17 |
| US6187809B1 (en) | 2001-02-13 |
| CN1295064A (zh) | 2001-05-16 |
| KR19990077162A (ko) | 1999-10-25 |
| CN1083831C (zh) | 2002-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69630319D1 (de) | Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten | |
| BR1100131A (pt) | ácidos hidroxâmicos substituìdos por arilsulfonamido | |
| DE69002248D1 (de) | 1,2-cyclohexylaminoarylamide zu verwendung als analgetika. | |
| HUT42272A (en) | Insecticides containing derivatives of nitro-methilen and process for production of the derivatives of nitromethilen | |
| PT687251E (pt) | Derivados de 1,3-di-hidro-indol-2-ona, substituidos na posicao 3 por um grupo azoto , como agonistas ou antagonistas da vasopressina e/ou ocitocina | |
| NZ240676A (en) | Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof | |
| EP1006122A4 (de) | Phenylethylenamin-derivate | |
| HU9400250D0 (en) | Quinoline-or quinazoine derivatives process fop producing them and pharmaceutical compositions containing them | |
| HUT66182A (en) | Tricyclic condensed heterocyclic compounds, process for producing them and pharmaceutical compositions contaning them as active component | |
| LV11738A (lv) | Tropan-2-aldoksima atvasinajumi ka neiromediatoru resorbcijas inhibitori | |
| ATE321759T1 (de) | Neue amidverbindungen und medikamente die diese enthalten | |
| PT649846E (pt) | Derivados da galantamina processo para a sua preparacao e sua utilizacao como medicamentos | |
| EP0604354A3 (de) | Antidepressiv und gegen die Parkinsonsche Krankheit wirkende Verbindungen. | |
| NZ228065A (en) | 1,2,4-triazinediones and parasiticidal compositions; processes for preparation | |
| GR3023934T3 (en) | New naphthalene amides and sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
| PT95651A (pt) | Processo para a preparacao de derivados de benzo-ciclo-alquilamino-piridinaminas e de composicoes farmaceuticas que os contem | |
| ATE303991T1 (de) | Aralkyltetrahydropyridine, deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
| ATE399778T1 (de) | Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon | |
| NO984263D0 (no) | Indolomorfinan-derivat og middel for herding og forebygging av cerebral forstyrrelse | |
| EP1020451A4 (de) | Neue anilidverbindungen und medikamente, die diese enthalten | |
| BR9705662A (pt) | Piridinas substituìdas. | |
| HU9601701D0 (en) | Aromatic hydroxamic acid compounds, process for producing them and their use | |
| EP0426018A3 (en) | Thiophene compounds and their pharmaceutical uses | |
| MA21913A1 (fr) | Procede de preparation de derives amino-oligohydroxy inhibiteurs de la renine . | |
| ATE245161T1 (de) | Verfahren zur synthese von phosphororganischen verbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0882707 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |